HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹70 Cr | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr |
What is the latest Consolidated Net Profit of HIKAL ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹78 Cr |
| Mar2023 | ₹160 Cr |
| Mar2022 | ₹133 Cr |
| Mar2021 | ₹84 Cr |
How is Consolidated Net Profit of HIKAL Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | -11.20 | |
| Mar2024 | ₹78 Cr | -51.16 | |
| Mar2023 | ₹160 Cr | 20.55 | |
| Mar2022 | ₹133 Cr | 57.68 | |
| Mar2021 | ₹84 Cr | - | |
Compare Consolidated Net Profit of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,684.9 Cr | -0.6% | 14.7% | -38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.6% |
14.7% |
-38.8% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses